{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:07:55Z","timestamp":1792782475350,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Armed police equipment research of China","award":["ZZKY20233109"],"award-info":[{"award-number":["ZZKY20233109"]}]},{"name":"Armed police Force discipline top talent fund","award":["ZG2020901"],"award-info":[{"award-number":["ZG2020901"]}]},{"name":"Armed police Force high-level science and technology personnel fund","award":["ZG202193"],"award-info":[{"award-number":["ZG202193"]}]},{"name":"Anhui Provincial Health Commission scientific research project","award":["AHWJ2023BAa20148"],"award-info":[{"award-number":["AHWJ2023BAa20148"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00210-024-03162-z","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T20:02:21Z","timestamp":1716580941000},"page":"8129-8143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Matrine inhibits invasion and migration of gallbladder cancer via regulating the PI3K\/AKT signaling pathway"],"prefix":"10.1007","volume":"397","author":[{"given":"Rong-Liang","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen-Cheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng-Qun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"issue":"1","key":"3162_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12943-023-01793-z","volume":"22","author":"A Akhmetkaliyev","year":"2023","unstructured":"Akhmetkaliyev A, Alibrahim N, Shafiee D, Eugene T (2023) EMT\/MET plasticity in cancer and go-or-grow decisions in quiescence: the two sides of the same coin? Mol Cancer 22(1):90","journal-title":"Mol Cancer"},{"issue":"4","key":"3162_CR2","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/med.21948","volume":"43","author":"HL Ang","year":"2023","unstructured":"Ang HL, Mohan CD, Shanmugam MK, Leong HC, Makvandi P, Rangappa KS, Bishayee A, Kuma AP, Sethi G (2023) Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds. Med Res Rev 43(4):1141\u20131200","journal-title":"Med Res Rev"},{"key":"3162_CR3","doi-asserted-by":"crossref","unstructured":"Cao L, Bridle KR, Shrestha R, Prithviraj P, Crawford DHG, Jayachandran A (2022) CD73 and PD-L1 as potential therapeutic targets in gallbladder cancer. Int J Mol Sci 23(3):1565","DOI":"10.3390\/ijms23031565"},{"key":"3162_CR4","doi-asserted-by":"publisher","first-page":"105778","DOI":"10.1016\/j.phrs.2021.105778","volume":"171","author":"MH Chen","year":"2021","unstructured":"Chen MH, Gu YY, Zhang AL, Sze DMY, Mo SL, May BH (2021) Biological effects and mechanisms of matrine and other constituents of Sophora flavescens in colorectal cancer. Pharmacol Res 171:105778","journal-title":"Pharmacol Res"},{"key":"3162_CR5","doi-asserted-by":"publisher","first-page":"216596","DOI":"10.1016\/j.canlet.2023.216596","volume":"582","author":"X Dai","year":"2024","unstructured":"Dai X, Chen W, Qiao Y, Chen XH, Chen YH, Zhang K, Zhang QS, Duan XX, Li X, Zhao JM, Tian F, Liu KD, Dong ZM, Lu J (2024) Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3\u03b2\/TCF7\/MMP9 pathway and synergies with capecitabine. Cancer Lett 582:216596","journal-title":"Cancer Lett"},{"key":"3162_CR6","doi-asserted-by":"publisher","first-page":"112654","DOI":"10.1016\/j.biopha.2022.112654","volume":"147","author":"Y Du","year":"2022","unstructured":"Du Y, Wan H, Huang P, Yang JH, He Y (2022) A critical review of astragalus polysaccharides: from therapeutic mechanisms to pharmaceutics. Biomed Pharmacother 147:112654","journal-title":"Biomed Pharmacother"},{"key":"3162_CR7","doi-asserted-by":"publisher","first-page":"154903","DOI":"10.1016\/j.phymed.2023.154903","volume":"117","author":"Y Fang Gong","year":"2023","unstructured":"Fang Gong Y, Hou S, Xu JC, Chen Y, Zhu LL, Xu YY, Chen YQ, Li MM, Li LL, Yang JJ, Yang Y (2023) Amelioratory effects of astragaloside IV on hepatocarcinogenesis via Nrf2-mediated pSmad3C\/3L transformation. Phytomedicine 117:154903","journal-title":"Phytomedicine"},{"key":"3162_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev-pathmechdis-051222-122423","volume":"19","author":"R Fontana","year":"2024","unstructured":"Fontana R, Mestre-Farrera A, Yang J (2024) Update on epithelial-mesenchymal plasticity in cancer progression. Annu Rev Patho 19:133\u2013156","journal-title":"Annu Rev Patho"},{"key":"3162_CR9","doi-asserted-by":"publisher","first-page":"110327","DOI":"10.1016\/j.biopha.2020.110327","volume":"128","author":"S Fu","year":"2020","unstructured":"Fu S, Zhao N, Jing G, Yang XM, Liu JF, Zhen DH, Tang XL (2020) Matrine induces papillary thyroid cancer cell apoptosis in vitro and suppresses tumor growth in vivo by downregulating miR-182-5p. Biomed Pharmacother 128:110327","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3162_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng HY, Nair MG, Makvandi P, Geoerger B, Kulke MH, Baird RD, Prabhu JS, Carbone D, Pecoraro C, The DBL, Sethi G, Cavalieri V, Lin KH, Javidi-Sharifi NR, Toska E, Davids MS, Brown JR, Diana P, Stebbing J, Fruman DA, Kumar AP (2023) PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer 22(1):138","journal-title":"Mol Cancer"},{"issue":"43","key":"3162_CR11","doi-asserted-by":"publisher","first-page":"12211","DOI":"10.3748\/wjg.v21.i43.12211","volume":"21","author":"TO Goetze","year":"2015","unstructured":"Goetze TO (2015) Gallbladder carcinoma: prognostic factors and therapeutic options. World J Gastroenterol 21(43):12211\u201312217","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3162_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 6(1):425. https:\/\/doi.org\/10.1038\/s41392-021-00828-5","journal-title":"Signal Transduct Target Ther"},{"key":"3162_CR13","doi-asserted-by":"crossref","unstructured":"Hu ZI, Lim KH (2022) Evolving paradigms in the systemic treatment of advanced gallbladder cancer: updates in year 2022. Cancers (Basel) 14(5):1249","DOI":"10.3390\/cancers14051249"},{"issue":"2","key":"3162_CR14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3892\/ijo.2016.3805","volume":"50","author":"H Huang","year":"2017","unstructured":"Huang H, Du T, Xu G, Lai YM, Fan XX, Chen XJ, Li WJ, Yue F, Li Q, Liu L, Li KW (2017) Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2\/9 via NF-\u03baB signaling pathway. Int J Oncol 50(2):640\u2013648","journal-title":"Int J Oncol"},{"issue":"Pt2","key":"3162_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.semcancer.2022.06.012","volume":"86","author":"IC Iser","year":"2022","unstructured":"Iser IC, Vedovatto S, Oliveira FD, Beckenkamp LR, Lenz G, Wink MR (2022) The crossroads of adenosinergic pathway and epithelial-mesenchymal plasticity in cancer. Semin Cancer Biol 86(Pt2):202\u2013213","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"3162_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhang H, Wang J, Liu YL, Luo T, Hua H (2022) Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol 15(1):34","journal-title":"J Hematol Oncol"},{"issue":"11","key":"3162_CR17","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S2468-1253(21)00171-0","volume":"6","author":"AE Kam","year":"2021","unstructured":"Kam AE, Masood A, Shroff RT (2021) Current and emerging therapies for advanced biliary tract cancers. Lancet Gastroenterol Hepatol 6(11):956\u2013969","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"3162_CR18","doi-asserted-by":"publisher","first-page":"189003","DOI":"10.1016\/j.bbcan.2023.189003","volume":"1878","author":"M Kielbik","year":"2023","unstructured":"Kielbik M, Przygodzka P, Szulc-Kielbik I, Klink M (2023) Snail transcription factors as key regulators of chemoresistance, stemness and metastasis of ovarian cancer cells. Biochim Biophys Acta Rev Cancer 1878(6):189003","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"5","key":"3162_CR19","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","volume":"22","author":"A Lamarca","year":"2021","unstructured":"Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, Falk S, Gillmore R, Wadsley J, Patel K, Anthoney A, Maraveyas A, Iveson T, Waters JS, Hobbs C, Barber S, Ryder WD, Ramage J, Davies LM, Bridgewater JA, Valle JW (2021) Advanced biliary cancer working group second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. Lancet Oncol 22(5):690\u2013701","journal-title":"Lancet Oncol"},{"issue":"7973","key":"3162_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-023-06372-2","volume":"620","author":"J Lengrand","year":"2023","unstructured":"Lengrand J, Pastushenko I, Vanuytven S, Song Y, Venet D, Sarate RM, Bellina M, Moers V, Boinet A, Sifrim A, Rama N, Ducarouge B, Herck JV, Dubois C, Scozzaro S, Lemaire S, Gieskes S, Bonni S, Collin A, Braissand N, Allard J, Zindy E, Decaestecker C, Sotiriou C, Salmon I, Mehlen P, Voet T, Bernet A, Blanpain C (2023) Pharmacological targeting of netrin-1 inhibits EMT in cancer. Nature 620(7973):402\u2013408","journal-title":"Nature"},{"issue":"5","key":"3162_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s11427-016-9050-6","volume":"61","author":"Q Li","year":"2018","unstructured":"Li Q, Huang H, He Z (2018) Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells. Sci China Life Sci 61(5):550\u2013558","journal-title":"Sci China Life Sci"},{"key":"3162_CR22","doi-asserted-by":"crossref","unstructured":"Li J, Wei S, Marabada D, Wang ZZ, Huang Q (2023) Research progress of natural Matrine compounds and synthetic Matrine derivatives. Molecules 28(15):5780","DOI":"10.3390\/molecules28155780"},{"key":"3162_CR23","doi-asserted-by":"publisher","first-page":"116778","DOI":"10.1016\/j.jep.2023.116778","volume":"317","author":"C Li","year":"2023","unstructured":"Li C, Niu D, Zhu R, Yan XY, Qu HR, Zhang YL, Zheng YL (2023a) Adjunctive effect of compound kushen injection for cancer: an overview of systematic reviews. J Ethnopharmacol 317:116778","journal-title":"J Ethnopharmacol"},{"key":"3162_CR24","doi-asserted-by":"publisher","first-page":"155661","DOI":"10.1016\/j.phymed.2024.155661","volume":"129","author":"Z Li","year":"2024","unstructured":"Li Z, Mo RL, Gong JF, Han L, Wang WF, Huang DK, Xu JG, Sun YJ, Chen S, Han GC, Sun DQ (2024) Dihydrotanshinone I inhibits gallbladder cancer growth by targeting the Keap1-Nrf2 signaling pathway and Nrf2 phosphorylation. Phytomedicine 129:155661","journal-title":"Phytomedicine"},{"key":"3162_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12935-017-0495-6","volume":"17","author":"XZ Liao","year":"2017","unstructured":"Liao XZ, Tao LT, Liu JH, Gu YY, Xie J, Chen YL, Lin MG, Liu TL, Wang DM, Guo HY, Mo SL (2017) Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF\/PI3K\/Akt signaling pathway. Cancer Cell Int 17:124","journal-title":"Cancer Cell Int"},{"issue":"6","key":"3162_CR26","doi-asserted-by":"publisher","first-page":"188998","DOI":"10.1016\/j.bbcan.2023.188998","volume":"1878","author":"Y Liao","year":"2023","unstructured":"Liao Y, Gui Y, Li Q, Li QZ, An J, Wang D (2023) The signaling pathways and targets of natural products from traditional Chinese medicine treating gastric cancer provide new candidate therapeutic strategies. Biochim Biophys Acta Rev Cancer 1878(6):188998","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3162_CR27","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3389\/fphar.2019.01069","volume":"10","author":"G Lin","year":"2019","unstructured":"Lin G, Wu Y, Cai F, Li Z, Su SX, Wang J, Cao JL, Ma LD (2019) Matrine promotes human myeloid leukemia cells apoptosis through warburg effect mediated by Hexokinase 2. Front Pharmacol 10:1069","journal-title":"Front Pharmacol"},{"issue":"1","key":"3162_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/aps.2016.104","volume":"38","author":"Y Liu","year":"2017","unstructured":"Liu Y, Qi Y, Bai ZH, Ni CX, Ren QH, Xu WH, Xu J, Hu HG, Qiu L, Li JZ, He ZG, Zhang JP (2017) A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K\/AKT signaling pathways. Acta Pharmacol Sin 38(1):120\u2013132","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"3162_CR29","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1016\/j.apsb.2023.06.009","volume":"13","author":"J Moreira","year":"2023","unstructured":"Moreira J, Machado M, Dias-Teixeira M, Ferraz R, Delerue-Matos C, Grosso C (2023) The neuroprotective effect of traditional Chinese medicinal plants-A critical review. Acta Pharm Sin B 13(8):3208\u20133237","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"3162_CR30","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jhep.2020.11.033","volume":"74","author":"C Nepal","year":"2021","unstructured":"Nepal C, Zhu B, O\u2019Rourke CJ, Bhatt DK, Lee D, Song L, Wang DF, Dyke ALV, Choo-Wosoba H, Liu ZW, Hildesheim A, Goldstein AM, Dean M, LaFuente-Barquero J, Lawrence S, Mutreja K, Olanich ME, Ferreccio C, Roa JC, Rashid A, Hsing AW, Gao YT, Chanock SJ, Araya JC, Andersen JB, Koshiol J (2021) Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes. J Hepatol 74(5):1132\u20131144","journal-title":"J Hepatol"},{"key":"3162_CR31","doi-asserted-by":"crossref","unstructured":"Pade\u017enik T, Oleksy A, Cokan A, Taka\u010d I, Sobo\u010dan M (2023) Changes in the extracellular matrix in endometrial and cervical cancer: a systematic review. Int J Mol Sci 24(6):5463","DOI":"10.3390\/ijms24065463"},{"issue":"5","key":"3162_CR32","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, Iveson T, Raftery J, Zhu SH, Cunningham D, Garden OJ, Stubbs C, Valle JW, Bridgewater J (2019) Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol 20(5):663\u2013673","journal-title":"Lancet Oncol"},{"key":"3162_CR33","doi-asserted-by":"crossref","unstructured":"Queiroz MM, Lima NF, Castria TBD (2023) Immunotherapy and targeted therapy for advanced biliary tract cancer: adding new flavors to the pizza. Cancers (Basel) 15(7):1970","DOI":"10.3390\/cancers15071970"},{"issue":"1","key":"3162_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garc\u00eda P, Kapoor VK, Maithel SK, Javle M, Koshiol J (2022) Gallbladder cancer. Nat Rev Dis Primers 8(1):69","journal-title":"Nat Rev Dis Primers"},{"key":"3162_CR35","doi-asserted-by":"crossref","unstructured":"Schepis T, Bo\u0161koski I, Tringali A, Vincenzo B (2022) Palliation in gallbladder cancer: the role of gastrointestinal endoscopy. Cancers (Basel) 14(7):1686","DOI":"10.3390\/cancers14071686"},{"issue":"4","key":"3162_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21037\/cco.2019.08.13","volume":"8","author":"MA Schmidt","year":"2019","unstructured":"Schmidt MA, Marcano-Bonilla L, Roberts LR (2019) Gallbladder cancer: epidemiology and genetic risk associations. Chin Clin Oncol 8(4):31","journal-title":"Chin Clin Oncol"},{"issue":"22","key":"3162_CR37","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","volume":"23","author":"A Sharma","year":"2017","unstructured":"Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A (2017) Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J Gastroenterol 23(22):3978\u20133998","journal-title":"World J Gastroenterol"},{"key":"3162_CR38","doi-asserted-by":"crossref","unstructured":"Sturm N, Schuhbaur JS, H\u00fcttner F, Perkhofer L, Ettrich TJ (2022) Gallbladder cancer: current multimodality treatment concepts and future directions. Cancers (Basel) 14(22):5580","DOI":"10.3390\/cancers14225580"},{"key":"3162_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","volume":"80","author":"D Tewari","year":"2022","unstructured":"Tewari D, Patni P, Bishayee A, Sah AN, Bishayee A (2022) Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy. Semin Cancer Biol 80:1\u201317","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"3162_CR40","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1038\/s41598-021-83924-4","volume":"11","author":"C Tong","year":"2021","unstructured":"Tong C, Wang Y, Li J, Cen WD, Zhang WG, Zhu ZY, Yu JH, Lu BC (2021) Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K\/Akt pathway. Sci Rep 11(1):4391","journal-title":"Sci Rep"},{"issue":"6","key":"3162_CR41","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s11010-022-04579-x","volume":"478","author":"K Tripathi","year":"2023","unstructured":"Tripathi K, Maurya N, Goel A, Singhai A, Garg M (2023) Immunohistochemical expressions of EMT markers in pan-RAS-pERK1\/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients. Mol Cell Biochem 478(6):1169\u20131190","journal-title":"Mol Cell Biochem"},{"issue":"14","key":"3162_CR42","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362(14):1273\u20131281","journal-title":"N Engl J Med"},{"key":"3162_CR43","doi-asserted-by":"crossref","unstructured":"Vega EA, Mellado S, Salehi O, Freeman R, Conrad C (2022) Treatment of resectable gallbladder cancer. Cancers (Basel) 14(6):1413","DOI":"10.3390\/cancers14061413"},{"key":"3162_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.semcancer.2023.02.001","volume":"90","author":"J Verstappe","year":"2023","unstructured":"Verstappe J, Berx G (2023) A role for partial epithelial-to-mesenchymal transition in enabling stemness in homeostasis and cancer. Semin Cancer Biol 90:15\u201328","journal-title":"Semin Cancer Biol"},{"key":"3162_CR45","doi-asserted-by":"publisher","first-page":"105728","DOI":"10.1016\/j.phrs.2021.105728","volume":"170","author":"S Wang","year":"2021","unstructured":"Wang S, Fu JL, Hao HF, Jiao YN, Li PP, Han SY (2021) Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol Res 170:105728","journal-title":"Pharmacol Res"},{"key":"3162_CR46","doi-asserted-by":"publisher","first-page":"153756","DOI":"10.1016\/j.phymed.2021.153756","volume":"95","author":"Q Wang","year":"2022","unstructured":"Wang Q, Li Y, Li KW, Zhou CZ (2022) Sophoridine: a review of its pharmacology, pharmacokinetics and toxicity. Phytomedicine 95:153756","journal-title":"Phytomedicine"},{"issue":"3","key":"3162_CR47","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1142\/S0192415X23500283","volume":"51","author":"S Wang","year":"2023","unstructured":"Wang S, Yang S, Yang X, Deng D, Li J, Dong MQ (2023) Research progress of traditional Chinese medicine monomers in reversing multidrug resistance of breast cancer. Am J Chin Med 51(3):575\u2013594","journal-title":"Am J Chin Med"},{"issue":"2","key":"3162_CR48","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7150\/ijbs.54074","volume":"17","author":"D Wei","year":"2021","unstructured":"Wei D, Rui B, Qingquan F, Chen C, Ping HY, Xiaoling S, Hao W, Jun G (2021) KIF11 promotes cell proliferation via ERBB2\/PI3K\/AKT signaling pathway in gallbladder cancer. Int J Biol Sci 17(2):514\u2013526","journal-title":"Int J Biol Sci"},{"key":"3162_CR49","doi-asserted-by":"publisher","first-page":"01067","DOI":"10.3389\/fphar.2020.01067","volume":"11","author":"L You","year":"2020","unstructured":"You L, Yang C, Du Y, Wang WP, Sun MY, Liu J, Ma BR, Pang LN, Zeng YW, Zhang ZQ, Dong X, Yin XB, Ni J (2020) A systematic review of the pharmacology, toxicology and pharmacokinetics of Matrine. Front Pharmacol 11:01067","journal-title":"Front Pharmacol"},{"key":"3162_CR50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P (2022) Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Bio 85:69\u201394","journal-title":"Semin Cancer Bio"},{"key":"3162_CR51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3389\/fphar.2020.00588","volume":"11","author":"H Zhang","year":"2020","unstructured":"Zhang H, Chen L, Sun X, Yang QJ, Wan LL, Guo C (2020) Matrine: a promising natural product with various pharmacological activities. Front Pharmacol 11:588","journal-title":"Front Pharmacol"},{"issue":"5","key":"3162_CR52","doi-asserted-by":"publisher","first-page":"739","DOI":"10.7150\/ijbs.40516","volume":"16","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Du P, Li Y, Zhu Q, Song XL, Liu SB, Hao JQ, Liu LG, Liu FT, Hu YP, Jiang L, Ma Q, Lu W, Liu YB (2020b) TASP1 promotes gallbladder cancer cell proliferation and metastasis by up-regulating FAM49B via PI3K\/AKT pathway. Int J Biol Sci 16(5):739\u2013751","journal-title":"Int J Biol Sci"},{"issue":"8","key":"3162_CR53","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S1470-2045(21)00343-0","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang N, Ng AS, Cai S, Li Q, Yang L, Kerr D (2021) Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer. Lancet Oncol 22(8):e358\u2013e368","journal-title":"Lancet Oncol"},{"issue":"1","key":"3162_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41419-021-04465-2","volume":"13","author":"F Zhang","year":"2021","unstructured":"Zhang F, Xiang S, Cao Y, Li ML, Ma Q, Liang HB, Li HF, Ye YY, Zhang YJ, Jiang L, Hu YP, Zhou J, Wang XF, Zhang Y, Nie L, Liang X, Gong W, Liu YB (2021a) Correction: EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway. Cell Death Dis 13(1):19","journal-title":"Cell Death Dis"},{"key":"3162_CR55","doi-asserted-by":"publisher","first-page":"114413","DOI":"10.1016\/j.biopha.2023.114413","volume":"160","author":"X Zhang","year":"2023","unstructured":"Zhang X, Gao Y, Zhou Y, Liu ZM, Liu RX (2023) Pharmacological mechanism of natural drugs and their active ingredients in the treatment of arrhythmia via calcium channel regulation. Biomed Pharmacother 160:114413","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3162_CR56","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s13402-018-0410-8","volume":"42","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Peng Y, Wu X, Meng SY, Yu W, Zhao JH, Zhang HY, Wang J, Li WB (2019) CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K\/Akt pathway in gallbladder cancer. Cell Oncol (Dordr) 42(1):81\u201392","journal-title":"Cell Oncol (Dordr)"},{"issue":"2","key":"3162_CR57","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/med.21989","volume":"44","author":"Y Zou","year":"2024","unstructured":"Zou Y, Wang S, Zhang H, Gu YX, Chen HJ, Huang ZH, Yang FF, Li WQ, Chen C, Men LH, Tian QC, Xie T (2024) The triangular relationship between traditional Chinese medicines, intestinal flora, and colorectal cancer. Med Res Rev 44(2):539\u2013567","journal-title":"Med Res Rev"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03162-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03162-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03162-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T09:09:10Z","timestamp":1727946550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03162-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["3162"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03162-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,25]]},"assertion":[{"value":"20 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal researches were performed according to the Experimental Animal Ethics Committee of Anhui University of Traditional Chinese Medicine (license number: AU AHUCM-mouce-2024017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}